tetra-O-methyl nordihydroguaiaretic acid
Term · Oncology and biomedicine · MLC-T-ONC-008624
A substance being studied in the treatment of cancer. It blocks proteins needed for cancer growth. It is a type of transcriptional inhibitor. Also called EM-1421 and tetra-O-methyl NDGA.
| Identifier | MLC-T-ONC-008624 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | EM-1421; tetra-O-methyl NDGA |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008624",
"term": "tetra-O-methyl nordihydroguaiaretic acid",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of cancer. It blocks proteins needed for cancer growth. It is a type of transcriptional inhibitor. Also called EM-1421 and tetra-O-methyl NDGA.",
"synonyms": [
"EM-1421",
"tetra-O-methyl NDGA"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/tetra-o-methyl-nordihydroguaiaretic-acid/"
}
Record 16,206 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.